BRIEF—New chief executive at Bristol Myers Squibb

Bristol Myers Squibb has announced the retirement of chief executive Giovanni Caforio from November 1, with current chief commercialization officer Christopher Boerner set to take the top job.

Dr Boerner will step up to the role of chief operating officer immediately, in preparation for the role, with major markets head Adam Lenkowsky ready to fill the CCO position.

Commenting on his appointment, Dr Boerner said: “Today, we are poised to bring the next wave of innovative medicines to market, and my confidence in our future is stronger than ever.”

Chief commercialization officer since August 2018, Dr Boerner previously served as head of international markets and head of US commercial markets at the company.

Before joining Bristol Myers in 2015 he held senior roles at Seattle Genetics, and before that Genentech, a member of the Roche group.